Provisional approval for adolescent bivalent booster

Moderna’s bivalent Covid-19 vaccine (elasomeran and davesomeran) has been granted provisional approval for use as a booster in adolescents aged 12 years and older  The vaccine is the second targeting the Omicron BA.4 and BA.5 subvariants to get the green light from the Therapeutic Goods Administration (TGA), with Pfizer’s Comirnaty Bivalent Omicron BA.4/BA.5 jab being